The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Sino Biopharmaceutical's share price is HK$2.88.
Sino Biopharmaceutical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.54. Hence, Sino Biopharmaceutical's PS Ratio for today is 1.87.
The historical rank and industry rank for Sino Biopharmaceutical's PS Ratio or its related term are showing as below:
HKSE:01177'
s PS Ratio Range Over the Past 10 Years
Min: 1.52 Med: 3.34 Max: 8.21
Current: 1.86
During the past 13 years, Sino Biopharmaceutical's highest PS Ratio was 8.21. The lowest was 1.52. And the median was 3.34.
HKSE:01177's PS Ratio is ranked better than 86.6% of 1000
companies
in the Biotechnology industry
Industry Median: 9.055
vs HKSE:01177: 1.86
Sino Biopharmaceutical Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Sino Biopharmaceutical was 1.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 1.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 3.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 8.90% per year.
During the past 13 years, Sino Biopharmaceutical's highest 3-Year average Revenue per Share Growth Rate was 64.10% per year. The lowest was -36.70% per year. And the median was 15.90% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sino Biopharmaceutical's PS Ratio
For the Biotechnology subindustry, Sino Biopharmaceutical's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sino Biopharmaceutical's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's PS Ratio distribution charts can be found below:
* The bar in red indicates where Sino Biopharmaceutical's PS Ratio falls into.
Sino Biopharmaceutical PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Sino Biopharmaceutical's Share Price of today is HK$2.88.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sino Biopharmaceutical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.54.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Sino Biopharmaceutical (HKSE:01177) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Sino Biopharmaceutical PS Ratio Related Terms
Thank you for viewing the detailed overview of Sino Biopharmaceutical's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Sino Biopharmaceutical (HKSE:01177) Business Description
Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01177 has been successfully added to your 